Stocks Screener

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

BioMark Diagnostics Inc

20B
Current price
0.14 EUR +0.005 EUR (+3.68%)
Last closed 0.25 CAD
ISIN CA09073K1084
Sector Healthcare
Industry Diagnostics & Research
Exchange Stuttgart Exchange
Capitalization 21 944 919 CAD
Yield for 12 month -14.29 %
1Y
3Y
5Y
10Y
15Y
20B
21.11.2021 - 28.11.2021

Biomark Diagnostics Inc., an oncology focused company, develops cancer diagnostic platform to detect, monitor, and treat cancer. The company invests in and develops liquid biopsy metabolic panel assay for early stage diagnosis of lung cancer. It has a strategic partnership with Rubix LS to develop diagnostic tools to enhance lung cancer screening and improve breast cancer screening program for women with dense breasts. The company was incorporated in 2014 and is headquartered in Richmond, Canada. Address: 3851 Shell Road, Richmond, BC, Canada, V6X 2W2

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

P/E ratio

Dividend Yield

Current Year

+164 210 CAD

Last Year

+154 420 CAD

Current Quarter

+40 046 CAD

Last Quarter

+41 795 CAD

Current Year

Last Year

Current Quarter

Last Quarter

Key Figures 20B

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -1 873 903 CAD
Operating Margin TTM -1515.23 %
PE Ratio
Return On Assets TTM -135.65 %
PEG Ratio
Return On Equity TTM
Wall Street Target Price
Revenue TTM 162 768 CAD
Book Value -0.007 CAD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY -3.6 %
Dividend Yield
Gross Profit TTM 44 199 CAD
Earnings per share -0.02 CAD
Diluted Eps TTM -0.02 CAD
Most Recent Quarter I 2024
Quarterly Earnings Growth YOY
Profit Margin

Dividend Analytics 20B

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History 20B

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor
Payout Ratio
Last Split Date
Dividend Date

Stock Valuation 20B

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue 137.6172
Price Sales TTM 134.8235
Enterprise Value EBITDA -27.3566
Price Book MRQ

Financials 20B

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators 20B

For 52 weeks

0.2 CAD 0.32 CAD
50 Day MA 0.23 CAD
Shares Short Prior Month 1 279
200 Day MA 0.27 CAD
Short Ratio 0.01
Shares Short 279
Short Percent 0.05 %

Dynamics of changes in the value of assets

3

3313

0.14 HKD ArtGo Mining Holding Ltd -0 (-1.41%)
Detailed analytics
O

OMIC

5.89 USD Singular Genomics Systems Inc -0.11 (-1.8%)
Detailed analytics
9

9353

1 669.00 JPY Sakurajima Futo Kaisha Ltd -0.02 (-0.18%)
Detailed analytics
X

XYTA

0.00050 EUR CHINA HUARONG ENER.HD-50 0 (0%)
Detailed analytics
A

ALIKO

1.47 EUR Ikonisys SA +0.01 (+0.68%)
Detailed analytics